Hot Pursuit     28-Jul-21
Shilpa Medicare gains on WHO nod for HIV drug
Shilpa Medicare rose 1.72% to Rs 634.35 after the company announced receipt of confirmation of WHO - GENEVA approval for API, Tenofovir Disoproxil Fumarate under pre-qualification program.

Tenofovir Disoproxil Fumarate is a medication used to treat chronic hepatitis B and to prevent and treat HIV/AIDS.

The announcement was made during market hours today.

Shilpa Medicare is a global brand in manufacturing and supplying of affordable API and formulation globally in different regulated markets.

On a consolidated basis, Shilpa Medicare's net profit slumped 77.35% to Rs 7.83 crore on 5.44% decrease in revenue from operations to Rs 208.03 crore in Q4 March 2021 over Q4 March 2020.

Previous News
  Shilpa Medicare Hyderabad unit clears USFDA inspection with zero observations
 ( Hot Pursuit - 25-Jun-24   14:18 )
  Shilpa Medicare gains on concluding human clinical studies of Adalimumab biosimilar
 ( Hot Pursuit - 22-Aug-22   13:24 )
  Shilpa Medicare to discuss results
 ( Corporate News - 04-Aug-22   16:09 )
  Shilpa Biologicals completes Human Clinical Studies of its Adalimumab biosimilar
 ( Corporate News - 19-Aug-22   15:53 )
  Shilpa Medicare's Telangana facility clears ANVISA, Brazil inspection
 ( Hot Pursuit - 25-Aug-23   12:25 )
  Shilpa Medicare consolidated net profit declines 98.16% in the June 2021 quarter
 ( Results - Announcements 14-Aug-21   17:05 )
  Shilpa Medicare reports consolidated net loss of Rs 18.66 crore in the September 2022 quarter
 ( Results - Announcements 12-Nov-22   08:12 )
  Shilpa Medicare receives Europe approval for Varenicline Tablets
 ( Corporate News - 26-Feb-24   11:06 )
  Shilpa Medicare Karnataka unit clears PMDA inspection
 ( Hot Pursuit - 04-Sep-23   10:04 )
  Volumes soar at Natco Pharma Ltd counter
 ( Hot Pursuit - 22-May-20   11:00 )
  Shilpa Medicare director resigns
 ( Corporate News - 03-Oct-20   09:59 )
Other Stories
  Dhanlaxmi Bank gains as gross advances rises 6% YoY in Q1 FY25
  05-Jul-24   15:27
  HDFC Bank Ltd leads losers in 'A' group
  05-Jul-24   15:00
  Shilpa Medicare sizzles after Unicycive gets positive results in clinical trials of OLC
  05-Jul-24   14:52
  Manugraph India Ltd leads losers in 'B' group
  05-Jul-24   14:45
  NSE SME Nephro Care India rallies on listing day
  05-Jul-24   14:45
  ESAF SFB total deposits jumps 33% YoY in Q1
  05-Jul-24   14:43
  Utkarsh SFB deposits climb 30% YoY in Q1 FY25
  05-Jul-24   14:35
  Volumes soar at Medplus Health Services Ltd counter
  05-Jul-24   14:30
  Financials stocks slide
  05-Jul-24   14:00
  Banking stocks edge lower
  05-Jul-24   14:00
Back Top